EAS modifying Phosphagain ad to eliminate "unsupported" takeaway messages -- NAD.
This article was originally published in The Tan Sheet
EXPERIMENTAL AND APPLIED SCIENCES MODIFYING PHOSPHAGAIN AD following a review by the National Advertising Division of the Council of Better Business Bureaus. In a recent Case Report, NAD concluded that although Experimental and Applied Sciences (EAS) adequately supported its ad claims for the "low calorie lean mass stimulator," there were "several potential unsupported, and not unreasonable, takeaway" messages.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC